Daily as of 3 Nov 16:00 ET
- Price
- below both $38.23 vs 50 $44.44 / 200 $52.34
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 13 Oct 2026 · projected 20 bars out
XENE | Xenon PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$38.23
+$0.61 (+1.62%)
Xenon Pharmaceuticals (XENE) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits below the 50 and the 200; on the 4-hour it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $37.41 vs 50 $50.38 / 200 $41.50
- Projection
- 💀Death cross estimated 15+ weeks out
- Test
- No active test
- Last cross
- 🟨Golden cross week of 16 Mar 2026 · projected 30 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $38.23 vs 50 $36.28 / 200 $53.33
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 21 Sep 2026 · projected 22 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 13 Oct 2026 | 💀Death steep | daily | 20 bars out | Not tested |
| 21 Sep 2026 | 💀Death | 4-hour | 22 bars out | Not tested |
| week of 16 Mar 2026 | 🟨Golden flat | weekly | 30 bars out | Not tested |
| 24 Feb 2026 | 🟨Golden | 4-hour | 2 bars out | 2 bar cross test |
| 20 Feb 2026 | 💀Death | 4-hour | not projected | 2 bar cross test |
About XENE
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$44.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmid